Search results
Postdoctoral Fellow in Immunology at Northwestern University - Chicago, Illinois job with Choi...
Nature· 36 minutes agoThe Choi lab (https://choilaboratory.northwestern.edu) is a T cell biology lab who is interested in improving outcomes for patients with cancer and autoimmune disease. 1) We are looking for ...
Understanding CAR T-cell therapy: A conversation with Northside’s Dr. Melhem Solh - Atlanta Business...
The Business Journals· 6 days agoDr. Melhem Solh, medical director of the cellular therapy program at Northside Hospital, answers...
Carl June compares his new CAR T-cell therapy to 'an armored truck or tank' - Philadelphia Business...
The Business Journals· 6 days agoDr. Carl June is seeking to take the cancer-fighting cell therapy he developed more than a dozen...
GRIT and Quangang announce IL-2 T-cell therapy partnership
Pharmaceutical Technology via Yahoo Finance· 6 days agoClinical-stage cell therapy company Shanghai Grit Biotechnology (GRIT) has formed a strategic...
New Guide Tackles Best Practices For Making Allogeneic Cell Therapies
BioresearchOnline· 6 days agoA comparatively thin body of GMP guidance supports a growing number of allogeneic cell therapies...
Celularity reports advances in cancer T-cell therapy By Investing.com
Investing.com· 6 days agoCelularity Inc. (NASDAQ: CELU), a biotechnology firm specializing in regenerative medicine,...
Kyverna Therapeutics to Present Data on 50 Patient Experience at Symposium at EULAR 2024
The Yuma Sun· 2 days agoA 12-month follow-up of the first patient treated with KYV-101 for myasthenia gravis will also be presented. The symposium titled "Anti-CD19 CAR T-Cell Therapy< ...
Health Beat: Do the benefits of CAR T-Cell therapy outweigh the risks?
WFMZ Eastern Pennsylvania and Western New Jersey· 5 days agoIn 2017, the FDA approved the first CAR T-cell therapy. Medical experts call it a "breakthrough" and...
Get Full Control Of Your T Cell Isolation For Your CAR T Cell Therapy Manufacturing
BioresearchOnline· 5 days agoCell therapies offer promising avenues for potentially treating malignancies that are currently...
Poseida Therapeutics Announces Virtual 2024 Annual Meeting of Stockholders
Tehachapi News· 6 days agoPoseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage allogeneic cell therapy and genetic medicines company advancing differentiated non-viral treatments ...